side effect difference between semaglutide and tirzepatide vs Tirzepatide: Head-to-Head for Weight Loss & Diabetes switching from semaglutide to tirzepatide

Standard FDA-approved dosing escalation The FDA-approved tirzepatide dosing schedule, used in the SURMOUNT and SURPASS clinical trials, follows this pattern: Weeks 1 to 4: 2.5 mg once weekly (starting dose) Weeks 5 to 8: 5 mg once weekly Weeks 9 to 12: 7.5 mg once weekly (optional increase) Weeks 13 to 16: 10 mg once weekly (optional increase) Weeks 17 to 20: 12.5 mg once weekly (optional increase) Week 21 and beyond: 15 mg once weekly (maximum dose) Each dose increase happens after a minimum of four weeks at the current dose

It reliably increases nausea, vomiting, and diarrhea

It also slows digestion and suppresses appetite, making it easier to maintain a calorie deficit for effective weight loss

Stephanie F

How quickly does tirzepatide suppress appetite

It works by stimulating two receptors in the body, known as the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors